ADL
PDLI

Asset Dedication LLC’s PDL BioPharma, Inc. PDLI Stock Holding History

Asset Dedication LLC’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-400
Closed -$1K – 667
2018
Q4 		$1K Buy
+400
New +$1.1K ﹤0.01% 580

Other funds holding PDLI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Asset Dedication LLC's PDLI Position: Q1 2019 in Review

Asset Dedication LLC sold out of PDL BioPharma, Inc. (PDLI) in Q1 2019, closing a stake of 400 shares — an estimated $1K sold.

Asset Dedication LLC first reported a position in PDLI in Q4 2018 and held it in 1 quarter. The position peaked at $1K in Q4 2018. 157 funds tracked by Wall St. Rank hold PDLI as of Q1 2019.

  • Asset Dedication LLC reported no remaining PDL BioPharma, Inc. position as of Q1 2019 after selling out during the quarter.
  • Asset Dedication LLC sold 400 PDL BioPharma, Inc. shares in Q1 2019, an estimated $1K.
  • Asset Dedication LLC first reported a position in PDL BioPharma, Inc. in Q4 2018 and held it in 1 quarter.
  • Asset Dedication LLC's PDL BioPharma, Inc. position peaked at $1K in Q4 2018.
  • 157 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q1 2019.

Based on Asset Dedication LLC's 13F filing for Q1 2019, filed 19 Apr 2019.